Funded Startups in Chengdu
The six most recent funding rounds tracked for Chengdu span September through November 2025, covering a diverse set of sectors — from aerospace with Aerofu…
The six most recent funding rounds tracked for Chengdu span September through November 2025, covering a diverse set of sectors — from aerospace with Aerofugia's Series C to food-and-beverage with Qilinyi Catering Management's $3M Series A. Five of the six rounds are Series A, indicating the current tracked cohort skews toward early-to-mid stage companies. Aerofugia is the outlier, closing a Series C on November 27, 2025 and standing as the most mature company by round stage in this set.
Disclosed amounts are scarce: Chengdu Maike, operating in manufacturing, 3D printing, hardware, and materials, reported a $14M Series A in October 2025, and Qilinyi raised $3M in September 2025. The remaining four rounds — including biotech companies Norn Gene and Kangdesai Medical Technology, and B2B software firm Paiz Interconnect — kept terms undisclosed. Biotechnology and healthcare account for two of the six entries, with both closing Series A rounds within a six-week window between late September and early November 2025.
Most recent rounds
6 shownRelated listings
Frequently asked
What round stages appear most often among recently funded Chengdu startups?
Five of the six companies in this set closed Series A rounds, including Paiz Interconnect, Norn Gene, Chengdu Maike, Kangdesai Medical Technology, and Qilinyi Catering Management. Aerofugia is the only Series C, closing November 27, 2025, making it the most advanced by stage.
How much funding has been publicly disclosed across these Chengdu rounds?
Only two of the six rounds carry disclosed figures: Chengdu Maike raised $14M in its Series A (October 2025) and Qilinyi Catering Management raised $3M (September 2025). The remaining four — including Aerofugia's Series C and rounds from Norn Gene, Kangdesai Medical Technology, and Paiz Interconnect — list undisclosed amounts.
Which sectors are represented in Chengdu's most recent funded cohort?
The six companies span aerospace and aviation (Aerofugia), B2B software and electronics (Paiz Interconnect), biotechnology and pharmaceuticals (Norn Gene), manufacturing and hardware (Chengdu Maike), healthcare and biotech (Kangdesai Medical Technology), and food and beverage (Qilinyi Catering Management). No single sector accounts for more than two companies in this dataset.
How active is biotech and healthcare investment in Chengdu based on this data?
Two of the six tracked companies fall into life sciences: Norn Gene (biotechnology, pharmaceuticals) closed a Series A on November 6, 2025, and Kangdesai Medical Technology (biotechnology, healthcare) closed a Series A on September 24, 2025. Both rounds were undisclosed.
How recent are the rounds shown, and how compressed is the deal activity?
The six rounds span roughly ten weeks, from Qilinyi Catering Management's September 18, 2025 close to Aerofugia's November 27, 2025 close. Three of the six rounds — Aerofugia, Paiz Interconnect, and Norn Gene — all closed within a single four-week window in November 2025.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.